Skip to main content
Signal8
KLEMP WALTER V profile photo

Walter V. Klemp

CIK: 0000938419

Transaction Breakdown

Open Market Buys (P)2 (7.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)7 (26.9%)

Derivative conversions

Awards (A)9 (34.6%)

Compensation grants

Other (G, F, J, C, D, …)8 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Moleculin Biotech, Inc. logo
MBRX

Moleculin Biotech, Inc.

DirectorOfficer
Autonomix Medical, Inc. logo
AMIX

Autonomix Medical, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (26 total)

  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Oct 15, 2026
    Tax Payment(F)
    Direct
    48.7K shares at avg. $0.37$18K
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Oct 15, 2026
    Exercise(M)
    Direct
    207.5K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Oct 15, 2026
    Award(A)

    Restricted Stock Units

    Direct
    415K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Oct 15, 2026
    Award(A)

    Options (right to buy)

    Direct
    415K shares-
  • Autonomix Medical, Inc. logo
    AMIX

    Autonomix Medical, Inc.

    Sep 3, 2026
    Award(A)
    Direct
    13K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Aug 3, 2026
    Purchase(P)
    Direct
    533.3K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Aug 3, 2026
    Award(A)

    Series I Warrants

    Direct
    1.6M shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 22, 2026
    Exercise(M)
    Direct
    360 shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 22, 2026
    Tax Payment(F)
    Direct
    88 shares at avg. $3.12$274.56
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 20, 2026
    Tax Payment(F)
    Direct
    37 shares at avg. $2.88$106.56
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 20, 2026
    Exercise(M)
    Direct
    150 shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Nov 12, 2025
    Award(A)

    Performance Based Restricted Stock Units

    Direct
    750K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Nov 12, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    830K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Nov 4, 2025
    Exercise(M)
    Direct
    28.8K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Nov 4, 2025
    Tax Payment(F)
    Direct
    7K shares at avg. $0.50$3K
  • Autonomix Medical, Inc. logo
    AMIX

    Autonomix Medical, Inc.

    Aug 11, 2025
    Disposition(D)

    Option (Right to buy)

    Direct
    8.8K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 23, 2025
    Purchase(P)
    Direct
    675.7K shares at avg. $0.37$250K
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 22, 2025
    Tax Payment(F)
    Direct
    2.2K shares at avg. $0.27$584.73
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 22, 2025
    Exercise(M)
    Direct
    9K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 20, 2025
    Tax Payment(F)
    Direct
    914 shares at avg. $0.27$244.038
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 20, 2025
    Exercise(M)
    Direct
    3.8K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 16, 2025
    Tax Payment(F)
    Direct
    406 shares at avg. $0.69$278.191
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Jun 16, 2025
    Exercise(M)
    Direct
    1.7K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Nov 4, 2024
    Award(A)

    Stock option (right to buy)

    Direct
    100K shares-
  • Moleculin Biotech, Inc. logo
    MBRX

    Moleculin Biotech, Inc.

    Nov 4, 2024
    Award(A)

    Restricted Stock Units

    Direct
    115K shares-

1-25 of 26

About KLEMP WALTER V

KLEMP WALTER V (SEC CIK 0000938419) files insider reports with the SEC as CEO and President of Moleculin Biotech, Inc. (MBRX) and Director of Autonomix Medical, Inc. (AMIX).

Signal8 holds 10 ownership filings by KLEMP WALTER V, all Form 4s, filed between Nov 6, 2024 and Oct 16, 2026. Those filings report 26 transactions, from Oct 25, 2024 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on KLEMP WALTER V's filings is in HOUSTON, TX.

Recent filings by KLEMP WALTER V

  • Oct 15, 2026: Tax withholding of MBRX shares (Form 4, code F).
  • Oct 15, 2026: Option exercise of MBRX shares (Form 4, code M).
  • Oct 15, 2026: Grants or awards of MBRX derivative securities (2 lines, Form 4, code A).
  • Sep 3, 2026: Grant or award of AMIX shares (Form 4, code A).
  • Aug 3, 2026: Open-market purchase of MBRX shares (Form 4, code P).

Other insiders filing for Moleculin Biotech, Inc. (MBRX)

How to read Form 4 transaction codes